Below, a list of constituents for BMED (BlackRock Future Health ETF) is shown. In total, BMED consists of 162 securities.
Note: The data shown here is as of date Apr 28, 2023 (the latest that can be sourced directly from the fund provider).
Click here to go back to the full list of ETFs.
Ticker | Name | Sector | Asset Class | Market Value | Weight (%) |
XTSLA | BLK CSH FND TREASURY SL AGENCY | Cash and/or Derivatives | Money Market | 230000.0 | 3.97 |
ALC | ALCON AG | Health Care | Equity | 167660.6 | 2.9 |
VRTX | VERTEX PHARMACEUTICALS INC | Health Care | Equity | 160548.18 | 2.77 |
BSX | BOSTON SCIENTIFIC CORP | Health Care | Equity | 157947.36 | 2.73 |
ABC | AMERISOURCEBERGEN CORP | Health Care | Equity | 140314.08 | 2.42 |
DXCM | DEXCOM INC | Health Care | Equity | 138626.67 | 2.39 |
WST | WEST PHARMACEUTICAL SERVICES INC | Health Care | Equity | 129586.21 | 2.24 |
SYK | STRYKER CORP | Health Care | Equity | 126626.5 | 2.19 |
MTD | METTLER TOLEDO INC | Health Care | Equity | 123937.38 | 2.14 |
ISRG | INTUITIVE SURGICAL INC | Health Care | Equity | 116443.14 | 2.01 |
COO | COOPER INC | Health Care | Equity | 111218.64 | 1.92 |
GILD | GILEAD SCIENCES INC | Health Care | Equity | 101101.22 | 1.75 |
PEN | PENUMBRA INC | Health Care | Equity | 98183.16 | 1.7 |
STE | STERIS | Health Care | Equity | 95543.55 | 1.65 |
MASI | MASIMO CORP | Health Care | Equity | 93081.0 | 1.61 |
PODD | INSULET CORP | Health Care | Equity | 89086.51 | 1.54 |
REGN | REGENERON PHARMACEUTICALS INC | Health Care | Equity | 88794.0 | 1.53 |
ALKS | ALKERMES | Health Care | Equity | 86582.34 | 1.5 |
ALNY | ALNYLAM PHARMACEUTICALS INC | Health Care | Equity | 86376.82 | 1.49 |
UCB | UCB SA | Health Care | Equity | 85742.33 | 1.48 |
HOLX | HOLOGIC INC | Health Care | Equity | 82064.28 | 1.42 |
RMD | RESMED INC | Health Care | Equity | 81416.16 | 1.41 |
QGEN | QIAGEN NV | Health Care | Equity | 79945.6 | 1.38 |
IQV | IQVIA HOLDINGS INC | Health Care | Equity | 76520.6 | 1.32 |
GXI | GERRESHEIMER AG | Health Care | Equity | 75601.9 | 1.31 |
BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | Equity | 75154.8 | 1.3 |
BIIB | BIOGEN INC | Health Care | Equity | 70547.0 | 1.22 |
TECH | BIO TECHNE CORP | Health Care | Equity | 62001.0 | 1.07 |
ABCM | ABCAM ADR PLC | Health Care | Equity | 61685.0 | 1.07 |
IONS | IONIS PHARMACEUTICALS INC | Health Care | Equity | 58074.25 | 1.0 |
BDX | BECTON DICKINSON | Health Care | Equity | 56652.75 | 0.98 |
WAT | WATERS CORP | Health Care | Equity | 55894.32 | 0.97 |
EXAS | EXACT SCIENCES CORP | Health Care | Equity | 53992.96 | 0.93 |
SGEN | SEAGEN INC | Health Care | Equity | 53534.12 | 0.92 |
BPMC | BLUEPRINT MEDICINES CORP | Health Care | Equity | 52805.54 | 0.91 |
IMCR | IMMUNOCORE HOLDINGS ADR PLC | Health Care | Equity | 52405.5 | 0.91 |
INCY | INCYTE CORP | Health Care | Equity | 51845.66 | 0.9 |
NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | Equity | 50037.44 | 0.86 |
BGNE | BEIGENE ADS REPRESENTING LTD | Health Care | Equity | 50019.2 | 0.86 |
ALGN | ALIGN TECHNOLOGY INC | Health Care | Equity | 48924.0 | 0.85 |
RGEN | REPLIGEN CORP | Health Care | Equity | 48505.4 | 0.84 |
ZTS | ZOETIS INC CLASS A | Health Care | Equity | 46923.24 | 0.81 |
NVCR | NOVOCURE LTD | Health Care | Equity | 45883.04 | 0.79 |
MRK | MERCK & CO INC | Health Care | Equity | 45233.04 | 0.78 |
STMN | STRAUMANN HOLDING AG | Health Care | Equity | 45020.67 | 0.78 |
RXDX | PROMETHEUS BIOSCIENCES INC | Health Care | Equity | 44339.09 | 0.77 |
ZBH | ZIMMER BIOMET HOLDINGS INC | Health Care | Equity | 44135.4 | 0.76 |
MCK | MCKESSON CORP | Health Care | Equity | 42917.6 | 0.74 |
APLS | APELLIS PHARMACEUTICALS INC | Health Care | Equity | 42660.6 | 0.74 |
LEGN | LEGEND BIOTECH ADR REP CORP | Health Care | Equity | 41957.56 | 0.72 |
BAX | BAXTER INTERNATIONAL INC | Health Care | Equity | 41949.95 | 0.72 |
INSP | INSPIRE MEDICAL SYSTEMS INC | Health Care | Equity | 41808.15 | 0.72 |
SWAV | SHOCKWAVE MEDICAL INC | Health Care | Equity | 40191.85 | 0.69 |
SAGE | SAGE THERAPEUTICS INC | Health Care | Equity | 40105.1 | 0.69 |
SRPT | SAREPTA THERAPEUTICS INC | Health Care | Equity | 38924.76 | 0.67 |
BRKR | BRUKER CORP | Health Care | Equity | 37336.97 | 0.65 |
AVTR | AVANTOR INC | Health Care | Equity | 36136.1 | 0.62 |
CTLT | CATALENT INC | Health Care | Equity | 35004.16 | 0.6 |
UTHR | UNITED THERAPEUTICS CORP | Health Care | Equity | 34972.42 | 0.6 |
CNMD | CONMED CORP | Health Care | Equity | 34238.7 | 0.59 |
SRT3 | SARTORIUS PREF AG | Health Care | Equity | 33981.07 | 0.59 |
OMCL | OMNICELL INC | Health Care | Equity | 33586.92 | 0.58 |
PTGX | PROTAGONIST THERAPEUTICS INC | Health Care | Equity | 32994.0 | 0.57 |
GMAB | GENMAB | Health Care | Equity | 32924.81 | 0.57 |
DALS | DA32 LIFE SCIENCE TECH ACQUISITION | Financials | Equity | 32509.82 | 0.56 |
RYTM | RHYTHM PHARMACEUTICALS INC | Health Care | Equity | 30791.25 | 0.53 |
CTEC | CONVATEC GROUP PLC | Health Care | Equity | 30631.69 | 0.53 |
KRTX | KARUNA THERAPEUTICS INC | Health Care | Equity | 30140.85 | 0.52 |
RETA | REATA PHARMACEUTICALS INC CLASS A | Health Care | Equity | 30045.46 | 0.52 |
TXG | 10X GENOMICS INC CLASS A | Health Care | Equity | 29320.2 | 0.51 |
IRTC | IRHYTHM TECHNOLOGIES INC | Health Care | Equity | 29056.5 | 0.5 |
ROG | ROCHE HOLDING PAR AG | Health Care | Equity | 29046.02 | 0.5 |
PTCT | PTC THERAPEUTICS INC | Health Care | Equity | 28236.8 | 0.49 |
RCM | R1 RCM INC | Health Care | Equity | 27635.64 | 0.48 |
EXEL | EXELIXIS INC | Health Care | Equity | 27518.46 | 0.48 |
UNH | UNITEDHEALTH GROUP INC | Health Care | Equity | 27476.9 | 0.47 |
NOVOB | NOVO NORDISK CLASS B | Health Care | Equity | 27240.79 | 0.47 |
MORF | MORPHIC HOLDING INC | Health Care | Equity | 24527.2 | 0.42 |
CERE | CEREVEL THERAPEUTICS HOLDINGS INC | Health Care | Equity | 24434.16 | 0.42 |
NUVL | NUVALENT INC CLASS A | Health Care | Equity | 23989.42 | 0.41 |
RVMD | REVOLUTION MEDICINES INC | Health Care | Equity | 23805.67 | 0.41 |
IMGN | IMMUNOGEN INC | Health Care | Equity | 23681.76 | 0.41 |
BLCO | BAUSCH LOMB CORP | Health Care | Equity | 22593.5 | 0.39 |
PRTA | PROTHENA PLC | Health Care | Equity | 22083.2 | 0.38 |
MRUS | MERUS NV | Health Care | Equity | 21840.25 | 0.38 |
BMEA | BIOMEA FUSION INC | Health Care | Equity | 21694.8 | 0.37 |
ARGX | ARGENX SE ADR | Health Care | Equity | 21373.2 | 0.37 |
PCVX | VAXCYTE INC | Health Care | Equity | 20900.76 | 0.36 |
HALO | HALOZYME THERAPEUTICS INC | Health Care | Equity | 20645.55 | 0.36 |
BIO | BIO RAD LABORATORIES INC CLASS A | Health Care | Equity | 20479.8 | 0.35 |
HZNP | HORIZON THERAPEUTICS PUBLIC PLC | Health Care | Equity | 19986.0 | 0.35 |
EHC | ENCOMPASS HEALTH CORP | Health Care | Equity | 19449.4 | 0.34 |
MLTX | MOONLAKE IMMUNOTHERAPEUTICS CLASS | Health Care | Equity | 19251.0 | 0.33 |
MRTX | MIRATI THERAPEUTICS INC | Health Care | Equity | 19130.0 | 0.33 |
GKOS | GLAUKOS CORP | Health Care | Equity | 18511.76 | 0.32 |
GLPG | GALAPAGOS ADR REPRESENTING NV | Health Care | Equity | 18325.32 | 0.32 |
GH | GUARDANT HEALTH INC | Health Care | Equity | 18170.79 | 0.31 |
AMED | AMEDISYS INC | Health Care | Equity | 18119.16 | 0.31 |
PRME | PRIME MEDICINE INC COM | Health Care | Equity | 17012.16 | 0.29 |
KROS | KEROS THERAPEUTICS INC | Health Care | Equity | 16865.31 | 0.29 |
HSKA | HESKA CORP | Health Care | Equity | 16777.6 | 0.29 |
PACB | PACIFIC BIOSCIENCES OF CALIFORNIA | Health Care | Equity | 15783.3 | 0.27 |
HKD | HKD CASH | Cash and/or Derivatives | Cash | 15762.55 | 0.27 |
CRSP | CRISPR THERAPEUTICS AG | Health Care | Equity | 15600.0 | 0.27 |
RCKT | ROCKET PHARMACEUTICALS INC | Health Care | Equity | 14938.56 | 0.26 |
ARVN | ARVINAS INC | Health Care | Equity | 14890.43 | 0.26 |
VKTX | VIKING THERAPEUTICS INC | Health Care | Equity | 14482.0 | 0.25 |
GPCR | STRUCTURE THERAPEUTICS INC | Health Care | Equity | 14272.71 | 0.25 |
SIBN | SI BONE INC | Health Care | Equity | 11809.28 | 0.2 |
TNDM | TANDEM DIABETES CARE INC | Health Care | Equity | 11592.36 | 0.2 |
RARE | ULTRAGENYX PHARMACEUTICAL INC | Health Care | Equity | 11288.7 | 0.2 |
NYXH | NYXOAH SA | Health Care | Equity | 11244.96 | 0.19 |
LUNG | PULMONX CORP | Health Care | Equity | 11233.62 | 0.19 |
STAA | STAAR SURGICAL | Health Care | Equity | 10847.6 | 0.19 |
GMAB | GENMAB SPONSORED ADR | Health Care | Equity | 10763.04 | 0.19 |
RCUS | ARCUS BIOSCIENCES INC | Health Care | Equity | 10084.8 | 0.17 |
HLN | HALEON AMERICAN DEPOSITARY SHARES | Consumer Staples | Equity | 10067.9 | 0.17 |
TCRX | TSCAN THERAPEUTICS INC | Health Care | Equity | 9562.43 | 0.17 |
ISEE | IVERIC BIO INC | Health Care | Equity | 8937.05 | 0.15 |
ARWR | ARROWHEAD PHARMACEUTICALS INC | Health Care | Equity | 8291.5 | 0.14 |
PLRX | PLIANT THERAPEUTICS INC | Health Care | Equity | 8151.07 | 0.14 |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | Health Care | Equity | 7380.0 | 0.13 |
TWST | TWIST BIOSCIENCE CORP | Health Care | Equity | 7290.57 | 0.13 |
CVAC | CUREVAC NV | Health Care | Equity | 6552.0 | 0.11 |
MASS | 908 DEVICES | Information Technology | Equity | 5890.32 | 0.1 |
BAVA | BAVARIAN NORDIC | Health Care | Equity | 5861.93 | 0.1 |
VRDN | VIRIDIAN THERAPEUTICS ORS INC | Health Care | Equity | 5631.78 | 0.1 |
AURA | AURA BIOSCIENCES INC | Health Care | Equity | 5626.5 | 0.1 |
BHVN | BIOHAVEN LTD | Health Care | Equity | 4887.0 | 0.08 |
FDMT | 4D MOLECULAR THERAPEUTICS INC | Health Care | Equity | 4865.4 | 0.08 |
PMVP | PMV PHARMACEUTICALS INC | Health Care | Equity | 4164.48 | 0.07 |
IOVA | IOVANCE BIOTHERAPEUTICS INC | Health Care | Equity | 4048.0 | 0.07 |
MOR | MORPHOSYS AG | Health Care | Equity | 3802.46 | 0.07 |
FGEN | FIBROGEN INC | Health Care | Equity | 3200.52 | 0.06 |
SOPH | SOPHIA GENETICS SA | Health Care | Equity | 2742.17 | 0.05 |
VTYX | VENTYX BIOSCIENCES INC | Health Care | Equity | 2720.0 | 0.05 |
TNYA | TENAYA THERAPEUTICS INC | Health Care | Equity | 2704.56 | 0.05 |
GLUE | MONTE ROSA THERAPEUTICS INC | Health Care | Equity | 2600.64 | 0.04 |
BBIO | BRIDGEBIO PHARMA INC | Health Care | Equity | 2566.8 | 0.04 |
MGNX | MACROGENICS INC | Health Care | Equity | 2527.2 | 0.04 |
KNTE | KINNATE BIOPHARMA INC | Health Care | Equity | 2344.72 | 0.04 |
ALLK | ALLAKOS INC | Health Care | Equity | 1942.5 | 0.03 |
DBTX | DECIBEL THERAPEUTICS INC | Health Care | Equity | 1479.07 | 0.03 |
GLTO | GALECTO INC | Health Care | Equity | 1335.9 | 0.02 |
RLAY | RELAY THERAPEUTICS INC | Health Care | Equity | 1089.65 | 0.02 |
DSGN | DESIGN THERAPEUTICS INC | Health Care | Equity | 1054.08 | 0.02 |
nan | ABIOMED CVRS Prvt | Health Care | Equity | 693.72 | 0.01 |
DKK | DKK/USD | Cash and/or Derivatives | Forwards | 679.73 | 0.01 |
GBP | GBP/USD | Cash and/or Derivatives | Forwards | 559.94 | 0.01 |
SGTX | SIGILON THERAPEUTICS INC | Health Care | Equity | 249.7 | 0.0 |
FREQ | FREQUENCY THERAPEUTICS INC | Health Care | Equity | 233.04 | 0.0 |
JPY | JPY CASH | Cash and/or Derivatives | Cash | 154.66 | 0.0 |
HKD | HKD/USD | Cash and/or Derivatives | FX | 12.69 | 0.0 |
EUR | EUR/USD | Cash and/or Derivatives | Forwards | -7.97 | 0.0 |
DKK | DKK/USD | Cash and/or Derivatives | Forwards | -204.63 | 0.0 |
EUR | EUR/USD | Cash and/or Derivatives | Forwards | -513.58 | -0.01 |
CHF | CHF/USD | Cash and/or Derivatives | Forwards | -633.23 | -0.01 |
AUD | AUD/USD | Cash and/or Derivatives | Forwards | -644.41 | -0.01 |
JPY | JPY/USD | Cash and/or Derivatives | Forwards | -2522.88 | -0.04 |
JPY | JPY/USD | Cash and/or Derivatives | Forwards | -2987.07 | -0.05 |
USD | USD CASH | Cash and/or Derivatives | Cash | -52093.74 | -0.9 |
The content contained herein is owned or licensed by BlackRock and/or its third-party information providers and is protected by applicable copyrights, trademarks, service marks, and/or other intellectual property rights. Such content is solely for your personal, non-commercial use. Accordingly, you may not copy, distribute, modify, post, frame or deep link this content. You may download material displayed on this Website for your personal use provided you also retain all copyright and other proprietary notices contained on the materials. Modification or use of the materials for any other purpose violates BlackRock's intellectual property rights. Holdings subject to change. See www.iShares.com for the most recent funds holdings. The values for “price” shown herein generally represent a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The values shown herein for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of the vendor price and may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent practicable date and may not necessarily be as of the date shown above. Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures. CAREFULLY CONSIDER THE FUNDS' INVESTMENT OBJECTIVES, RISK FACTORS, AND CHARGES AND EXPENSES BEFORE INVESTING. THIS AND OTHER INFORMATION CAN BE FOUND IN THE FUNDS' PROSPECTUSES OR, IF AVAILABLE, THE SUMMARY PROSPECTUSES WHICH MAY BE OBTAINED BY VISITING WWW.ISHARES.COM OR WWW.BLACKROCK.COM. READ THE PROSPECTUS CAREFULLY BEFORE INVESTING. INVESTING INVOLVES RISK, INCLUDING POSSIBLE LOSS OF PRINCIPAL. This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. The Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”). The iShares Funds are not sponsored, endorsed, issued, sold or promoted by Bloomberg, BlackRock Index Services, LLC, Cboe Global Indices, LLC, Cohen & Steers, European Public Real Estate Association (“EPRA® ”), FTSE International Limited (“FTSE”), ICE Data Indices, LLC, NSE Indices Ltd, JPMorgan, JPX Group, London Stock Exchange Group (“LSEG”), MSCI Inc., Markit Indices Limited, Morningstar, Inc., Nasdaq, Inc., National Association of Real Estate Investment Trusts (“NAREIT”), Nikkei, Inc., Russell, S&P Dow Jones Indices LLC or STOXX Ltd. None of these companies make any representation regarding the advisability of investing in the Funds. With the exception of BlackRock Index Services, LLC, who is an affiliate, BlackRock Investments, LLC is not affiliated with the companies listed above. Neither FTSE, LSEG, nor NAREIT makes any warranty regarding the FTSE Nareit Equity REITS Index, FTSE Nareit All Residential Capped Index or FTSE Nareit All Mortgage Capped Index. Neither FTSE, EPRA, LSEG, nor NAREIT makes any warranty regarding the FTSE EPRA Nareit Developed ex-U.S. Index, FTSE EPRA Nareit Developed Green Target Index or FTSE EPRA Nareit Global REITs Index. “FTSE®” is a trademark of London Stock Exchange Group companies and is used by FTSE under license. ©2023 BlackRock, Inc or its affiliates. All rights reserved. iSHARES, iBONDS and BLACKROCK are trademarks of BlackRock, Inc. or its affiliates. All other trademarks are those of their respective owners. iCRMH0323U/S-2742939 | nan | nan | nan | nan | nan |